| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 3 |
| 1 | ACETAMINOPHEN 500MG | 3 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 3 |
| 3 | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | 3 |
| 4 | AMISULPRIDE | 3 |
| 5 | ARIPIPRAZOLE | 3 |
| 6 | ARIPIPRAZOLE ORAL | 3 |
| 7 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 3 |
| 8 | IBUPFROFEN | 3 |
| 9 | IBUPROFEN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMISULPRIDE | 3 | 0.0005 |
| 1 | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | 3 | 0.0004 |
| 2 | GLYCERIN, LIDOCAINE | 1 | 0.0001 |
| 3 | DOCOSANOL | 1 | 0.0001 |
| 4 | ARIPIPRAZOLE | 3 | 0.0000 |
| 5 | PIOGLITAZONE | 1 | 0.0000 |
| 6 | FINASTERIDE | 1 | 0.0000 |
| 7 | IBUPFROFEN | 3 | 0.0000 |
| 8 | IBUPROFEN TABLETS USP, 200MG | 3 | 0.0000 |
| 9 | IBUPROFEN ORAL | 3 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 3 | 0.0004 |
| 1 | Non-Standardized Chemical Allergen [EPC] | 1 | 0.0000 |
| 2 | 5-alpha Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Atypical Antipsychotic [EPC] | 4 | 0.0000 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 3 | 0.0000 |
| 5 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3 | 0.0000 |
| 7 | Proton Pump Inhibitor [EPC] | 1 | 0.0000 |